Literature DB >> 9349235

Prognostic value of tumour-infiltrating lymphocytes (TILs) in colorectal cancer.

K M Ropponen1, M J Eskelinen, P K Lipponen, E Alhava, V M Kosma.   

Abstract

Clinical follow-up data of 276 colorectal adenocarcinoma patients treated in Kuopio University Hospital between 1976 and 1986 and followed up for a mean of 14 years were analysed. The clinical findings were correlated with tumour-infiltrating lymphocytes (TILs) and with histological and quantitative factors including nuclear parameters and volume-corrected mitotic index. In univariate survival analysis, TNM classification, Dukes' stage, histological grade, and TILs were significant predictors of survival. TNM classification, Dukes' stage, and TILs also predicted recurrence-free survival. In multivariate analysis, TILs were an independent prognostic factor of survival in all cases, as well as in patients with T1-4N0-3M0 and T1-4N1-3M1. TILs also independently predicted recurrence-free survival. TILs can provide important prognostic information in colorectal cancer to be used in evaluating for adjuvant therapy in different tumour stages.

Entities:  

Mesh:

Year:  1997        PMID: 9349235     DOI: 10.1002/(SICI)1096-9896(199707)182:3<318::AID-PATH862>3.0.CO;2-6

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  140 in total

1.  Analysis of FoxP3+ T-regulatory cells and CD8+ T-cells in ovarian carcinoma: location and tumor infiltration patterns are key prognostic markers.

Authors:  Cecilia Hermans; David Anz; Jutta Engel; Thomas Kirchner; Stefan Endres; Doris Mayr
Journal:  PLoS One       Date:  2014-11-03       Impact factor: 3.240

2.  High-level mRNA quantification of proliferation marker pKi-67 is correlated with favorable prognosis in colorectal carcinoma.

Authors:  Thomas Ihmann; Jian Liu; Wolfgang Schwabe; Peter Häusler; Detlev Behnke; Hans-Peter Bruch; Rainer Broll; Ute Windhövel; Michael Duchrow
Journal:  J Cancer Res Clin Oncol       Date:  2004-09-21       Impact factor: 4.553

3.  Expression of calreticulin is associated with infiltration of T-cells in stage IIIB colon cancer.

Authors:  Rui-Qing Peng; Ying-Bo Chen; Ya Ding; Rong Zhang; Xing Zhang; Xing-Juan Yu; Zhi-Wei Zhou; Yi-Xin Zeng; Xiao-Shi Zhang
Journal:  World J Gastroenterol       Date:  2010-05-21       Impact factor: 5.742

4.  The elevated preoperative derived neutrophil-to-lymphocyte ratio predicts poor clinical outcome in breast cancer patients.

Authors:  Sabine Krenn-Pilko; Uwe Langsenlehner; Tatjana Stojakovic; Martin Pichler; Armin Gerger; Karin S Kapp; Tanja Langsenlehner
Journal:  Tumour Biol       Date:  2015-07-29

5.  NF-κB hyperactivation in tumor tissues allows tumor-selective reprogramming of the chemokine microenvironment to enhance the recruitment of cytolytic T effector cells.

Authors:  Ravikumar Muthuswamy; Erik Berk; Beth Fallert Junecko; Herbert J Zeh; Amer H Zureikat; Daniel Normolle; The Minh Luong; Todd A Reinhart; David L Bartlett; Pawel Kalinski
Journal:  Cancer Res       Date:  2012-05-16       Impact factor: 12.701

6.  Recommendations for the reporting of surgically resected specimens of colorectal carcinoma.

Authors:  Jeremy R Jass; Michael J O'Brien; Robert H Riddell; Dale C Snover
Journal:  Virchows Arch       Date:  2006-11-25       Impact factor: 4.064

7.  Microsatellite instability and high content of activated cytotoxic lymphocytes identify colon cancer patients with a favorable prognosis.

Authors:  M Guidoboni; R Gafà; A Viel; C Doglioni; A Russo; A Santini; L Del Tin; E Macrì; G Lanza; M Boiocchi; R Dolcetti
Journal:  Am J Pathol       Date:  2001-07       Impact factor: 4.307

8.  Tumor lymphocyte immune response to preoperative radiotherapy in locally advanced rectal cancer: The LYMPHOREC study.

Authors:  C Mirjolet; C Charon-Barra; S Ladoire; F Arbez-Gindre; A Bertaut; F Ghiringhelli; A Leroux; D Peiffert; C Borg; J F Bosset; G Créhange
Journal:  Oncoimmunology       Date:  2017-11-27       Impact factor: 8.110

9.  Invasive front of colorectal cancer: dynamic interface of pro-/anti-tumor factors.

Authors:  Inti Zlobec; Alessandro Lugli
Journal:  World J Gastroenterol       Date:  2009-12-21       Impact factor: 5.742

10.  Low expression of chemokine receptor CCR5 in human colorectal cancer correlates with lymphatic dissemination and reduced CD8+ T-cell infiltration.

Authors:  Tim Zimmermann; Markus Moehler; Ines Gockel; George G Sgourakis; Stefan Biesterfeld; Michaela Müller; Martin R Berger; Hauke Lang; Peter R Galle; Carl C Schimanski
Journal:  Int J Colorectal Dis       Date:  2010-04       Impact factor: 2.571

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.